Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess, in the general diabetic population, 1) the prevalence of painful neuropathic symptoms; 2) the relationship between symptoms and clinical severity of neuropathy; and 3) the role of diabetes type, sex, and ethnicity in painful neuropathy. RESEARCH DESIGN AND METHODS: Observational study of a large cohort of diabetic patients receiving community-based health care in northwest England (n = 15,692). Painful diabetic neuropathy (PDN) was assessed using neuropathy symptom score (NSS) and neuropathy disability score (NDS). RESULTS: Prevalence of painful symptoms (NSS ≥5) and PDN (NSS ≥5 and NDS ≥3) was 34 and 21%, respectively. Painful symptoms occurred in 26% of patients without neuropathy (NDS ≤2) and 60% of patients with severe neuropathy (NDS >8). Adjusted risk of painful neuropathic symptoms in type 2 diabetes was double that of type 1 diabetes (odds ratio [OR] = 2.1 [95% CI 1.7–2.4], P < 0.001) and not affected by severity of neuropathy, insulin use, foot deformities, smoking, or alcohol. Women had 50% increased adjusted risk of painful symptoms compared with men (OR = 1.5 [1.4–1.6], P < 0.0001). Despite less neuropathy in South Asians (14%) than Europeans (22%) and African Caribbeans (21%) (P < 0.0001), painful symptoms were greater in South Asians (38 vs. 34 vs. 32%, P < 0.0001). South Asians without neuropathy maintained a 50% increased risk of painful neuropathy symptoms compared with other ethnic groups (P < 0.0001). CONCLUSIONS: One-third of all community-based diabetic patients have painful neuropathy symptoms, regardless of their neuropathic deficit. PDN was more prevalent in patients with type 2 diabetes, women, and people of South Asian origin. This highlights a significant morbidity due to painful neuropathy and identifies key groups who warrant screening for PDN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetic peripheral polyneuropathy (also known as diabetic neuropathy) affects 50% of patients with diabetes [3–5]”
From A Consideration of the Psychological Aspects to Managing Patients with Painful Diabetic Neuropathy: An Insight into Pain Management Services at a Tertiary Centre in the UK (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“with previous studies suggesting that it affects 21% of patients with neuropathy (23)”
From Development of a Core Outcome Set for Studies Assessing Interventions for Diabetes-Related Foot Ulceration (2024) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566
Self-citationYoung, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Self-citationAbbott, C. A., Carrington, A. L., Ashe, H., Bath, S., Every, L. C., Griffiths, J., Hann, A. W., Hussein, A., Jackson, N., Johnson, K. E., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00698.x · Cited by 1,056
Self-citationThe Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes
Davies, M., Brophy, S., Williams, R., & Taylor, A. (2006) · Diabetes Care · doi:10.2337/dc05-2228 · Cited by 746
Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D. (1996) · Diabetologia · doi:10.1007/s001250050586 · Cited by 695
Bril, V., England, J., Franklin, G. M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D. J., Perkins, B., Russell, J. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166ebe · Cited by 634
Daousi, C., MacFarlane, I. A., Woodward, A., Nurmikko, T. J., Bundred, P. E., & Benbow, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01271.x · Cited by 454
Foot complications in Type 2 diabetes: an Australian population‐based study
Tapp, R. J., Shaw, J. E., De Courten, M. P., Dunstan, D. W., Welborn, T. A., & Zimmet, P. Z. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00881.x · Cited by 193
Cabezas-Cerrato, J. (1998) · Diabetologia · doi:10.1007/s001250051063 · Cited by 192
Abbott, C. A., Garrow, A. P., Carrington, A. L., Morris, J., Van Ross, E. R., & Boulton, A. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1869 · Cited by 171
Self-citation
Cited by
Items 201–300 of 870
The vascular complications of diabetes: a review of their management, pathogenesis, and prevention
Meir, J., Huang, L., Mahmood, S., Whiteson, H. Z., Cohen, S., & Aronow, W. S. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2279533 · Cited by 48
Stubbs, E. B., Fisher, M. A., Miller, C. M., Jelinek, C. S., Butler, J., McBurney, C., & Collins, E. G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00051 · Cited by 45
“In as much as 20% of diabetic patients, unremitting painful neuropathy negatively impacts health-related quality of life (Abbott et al., 2011).”
BackgroundBonhof, C. S., Trompetter, H. R., Vreugdenhil, G., van de Poll-Franse, L. V., & Mols, F. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05438-5 · Cited by 46
Lawn, T., Aman, Y., Rukavina, K., Sideris-Lampretsas, G., Howard, M. A., Ballard, C. G., Chaudhuri, К. R., & Malcangio, M. (2020) · Pain · doi:10.1097/j.pain.0000000000002111 · Cited by 47
Botulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis
Lakhan, S. E., Velasco, D. N., & Tepper, D. (2015) · Pain Medicine · doi:10.1111/pme.12728 · Cited by 38
Griggs, R. B., Santos, D. F., Laird, D. E., Doolen, S., Donahue, R. R., Wessel, C. R., Fu, W., Sinha, G. P., Wang, P., Zhou, J., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.019 · Cited by 37
Pires, A. S., Heng, B., Tan, V. X., Latini, A., Russo, M. A., Santarelli, D. M., Bailey, D., Wynne, K., O'Brien, J. A., Guillemin, G. J., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00890 · Cited by 39
Painful Diabetic Peripheral Neuropathy: Presentations, Mechanisms, and Exercise Therapy
Yoo, M., Sharma, N. K., Pasnoor, M., & Kluding, P. M. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s10-005 · Cited by 47
“A common phenotype of DPN is painful diabetic neuropathy (P-DPN), as a fairly significant proportion of diabetic population, ranging between 10-26% depending on the sample population, experience P-DPN [7-9].”
BackgroundPain management in people with severe mental illness: an agenda for progress
Onwumere, J., Stubbs, B., Stirling, M., Shiers, D., Gaughran, F., Rice, A. S. C., C de C Williams, A., & Scott, W. (2022) · Pain · doi:10.1097/j.pain.0000000000002633 · Cited by 35
Yang, L., Lu, J., Guo, J., Chen, J., Xiong, F., Wang, X., Chen, L., & Yu, C. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0920-22.2022 · Cited by 41
Zhang, Q., Yi, N., Liu, S., Zheng, H., Qiao, X., Xiong, Q., Liu, X., Zhang, S., Wen, J., Ye, H., et al. (2018) · Journal of International Medical Research · doi:10.1177/0300060518775244 · Cited by 42
Zheng, Y., Yang, F., Han, L., Gou, X., Lian, F., Liu, W., Zhao, L., Pang, B., Zhao, X., & Tong, X. (2019) · Journal of Diabetes Research · doi:10.1155/2019/4035861 · Cited by 36
“showed that the prevalence of pDPN was 60% among patients affected by severe DPN [6].”
BackgroundAmyloid Proteins and Peripheral Neuropathy
Albariqi, M. M. H., Engelsman, S., Eijkelkamp, N., & Höppener, J. W. M. (2020) · Cells · doi:10.3390/cells9061553 · Cited by 41
Galan, V., Scowcroft, J. A., Chang, P., Li, S., Staats, P. S., Rotte, A., & Subbaroyan, J. (2020) · Pain Management · doi:10.2217/pmt-2020-0033 · Cited by 37
Bäckryd, E., Themistocleous, A. C., Larsson, A. O., Gordh, T., Rice, A. S. C., Tesfaye, S. H., Bennett, D., & Gerdle, B. U. C. (2021) · Pain · doi:10.1097/j.pain.0000000000002451 · Cited by 36
“Although the presented OPLS-DA regressions (group 2 vs Group [1 1 3]) were highly significant, they only explained half (45%-46”
InfluentialBhandari, R., Sharma, A., & Kuhad, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.790747 · Cited by 41
Diabetes mellitus in classical trigeminal neuralgia: A predisposing factor for its development
Xu, Z., Zhang, P., Li, L., et al. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.10.015 · Cited by 34
Meng, Y., Preston, F., Ferdousi, M., Azmi, S., Petropoulos, I. N., Kaye, S. B., Malik, R. A., Alam, U., & Zheng, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041284 · Cited by 38
“Neuropathic pain is a major feature of DPN, affecting around one-third of all patients and associated with increased morbidity [15].”
BackgroundSelf-citationLiu, D., Liang, X., & Zhang, H. (2016) · Neurochemical Research · doi:10.1007/s11064-015-1824-6 · Cited by 38
Methylglyoxal Requires AC1 and TRPA1 to Produce Pain and Spinal Neuron Activation
Griggs, R. B., Laird, D. E., Donahue, R. R., Fu, W., & Taylor, B. K. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00679 · Cited by 33
“Additional knowledge of the molecular mechanisms of diabetic pain is needed to develop better treatments for painful diabetic neuropathy, which affects one-third of diabetes patients (Davies et al., 2006; Abbott et al., 2011; Lee-Kubli et al., 2014).”
Unveiling the Role of Schwann Cell Plasticity in the Pathogenesis of Diabetic Peripheral Neuropathy
Razak, N. H. A., Idris, J., Hassan, N. H., Zaini, F., Muhamad, N., & Daud, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910785 · Cited by 39
“It is the most common complication among diabetic patients, affecting approximately 30% of them [1,2].”
BackgroundCardinez, N., Lovblom, L. E., Bai, J.-W., Lewis, E. J. H., Abraham, A., Scarr, D., Lovshin, J. A., Lytvyn, Y., Boulet, G., Farooqi, M. A., et al. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.001 · Cited by 35
Jin, G., Hong, L.-M., Liu, H., Yue, R., Shen, Z., Yang, J., Xu, Y., Huang, H., Li, Y., Xiong, B., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153640 · Cited by 32
Petersen, E., Stauss, T. G., Scowcroft, J. A., Brooks, E. S., White, J. L., Sills, S. M., Amirdelfan, K., Guirguis, M. N., Xu, J. J., Yu, C., et al. (2022) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2022.05.003 · Cited by 38
“Nearly half of the patients with DSPN develop painful diabetic neuropathy (PDN) causing extremity pain, paresthesia, burning, and shooting pain that is typically worse at night and disrupts sleep.(6,7) Painful diabetic neuropathy therapies target pain management and enhanced glycemic control to mitigate further nerve…”
BackgroundIs metformin a possible treatment for diabetic neuropathy?
Wei, J., Wei, Y., Huang, M., Wang, P., & Jia, S. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13310 · Cited by 34
“About 30% DPN patients have pain symptoms, including tingling, burning, spontaneous pain, allodynia and hyperalgesia.(2) However, the treatment of painful diabetic peripheral neuropathy (PDPN) has been unsatisfactory, and less than 30% PDPN patients can obtain satisfactory analgesic through therapy.”
BackgroundScreening for diabetic peripheral neuropathy in resource-limited settings
Nkonge, K. M., Nkonge, D. K., & Nkonge, T. N. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01032-x · Cited by 45
Discordance between preclinical and clinical testing of NaV1.7-selective inhibitors for pain
Yang, J., Xie, Y., Smith, R., Ratté, S., & Prescott, S. A. (2024) · Pain · doi:10.1097/j.pain.0000000000003425 · Cited by 45
Are Opioids Effective in Relieving Neuropathic Pain?
Schembri, E. (2018) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-018-0009-4 · Cited by 38
“Only 21% of patients with diabetic neuropathy suffer fromNP, but 60% of the patients with severe diabetic neuropathy suffer from NP [19].”
BackgroundEruca sativa Meal against Diabetic Neuropathic Pain: An H2S-Mediated Effect of Glucoerucin
Lucarini, E., Pagnotta, E., Micheli, L., Parisio, C., Testai, L., Martelli, A., Calderone, V., Matteo, R., Lazzeri, L., Mannelli, L. D. C., et al. (2019) · Molecules · doi:10.3390/molecules24163006 · Cited by 33
“Diabetic peripheral neuropathy is a distressing disease of the nerves in the hands and feet, it is a common complication of both type 1 and type 2 diabetes [1,39].”
BackgroundAleidan, F. A. S., Ahmed, B. A., Alotaibi, F., Aleesa, D. H., Al-Hefdhi, N., Badri, M., & Gader, A. G. A. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s273807 · Cited by 56
CLINICAL GUIDELINES FOR DIAGNOSIS AND TREATMENT OF DIABETIC FOOT SYNDROME
Galstyan, G. R., Tokmakova, A. Y., Egorova, D. N., Mitish, V. A., Paskhalova, Y. S., Antsiferov, M. B., Komelyagina, E., Удовиченко, О. В., Гурьева, И. В., Bregovskiy, V. B., et al. (2015) · Wounds and wound infections The prof B M Kostyuchenok journal · doi:10.17650/2408-9613-2015-2-3-63-83 · Cited by 32
Effects of acetyl-l-carnitine in diabetic neuropathy and other geriatric disorders
Sergi, G., Pizzato, S., Piovesan, F., Trevisan, C., Veronese, N., & Manzato, E. (2017) · Aging Clinical and Experimental Research · doi:10.1007/s40520-017-0770-3 · Cited by 38
Complementing Insulin Therapy to Achieve Glycemic Control
Barnett, A. H. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0039-y · Cited by 38
Garoushi, S., Johnson, M. I., & Tashani, O. A. (2019) · BMC Public Health · doi:10.1186/s12889-018-6374-9 · Cited by 32
Salehi, H., Moussaei, M., Kamiab, Z., & Vakilian, A. (2019) · Current Journal of Neurology · doi:10.18502/ijnl.v18i3.1632 · Cited by 40
Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link
Brzecka, A., Madetko‐Alster, N., Nikolenko, V. N., Ashraf, G. M., Ejma, M., Leszek, J., Daroszewski, C., Sarul, K., Михалева, Л. М., Somasundaram, S. G., et al. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200309101750 · Cited by 39
“5 Diabetes as a risk factor for sleep disturbances [41-49; 54-60]”
BackgroundState-of-the-art pharmacotherapy for diabetic neuropathy
Azmi, S., Alam, U., Burgess, J., & Malik, R. A. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1812578 · Cited by 32
Self-citationCorneal nerve loss is related to the severity of painful diabetic neuropathy
Kalteniece, A., Ferdousi, M., Azmi, S., Khan, S. U., Worthington, A., Marshall, A. G., Faber, C. G., Lauria, G., Boulton, A. J. M., Soran, H., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15129 · Cited by 31
“Painful diabetic neuropathy (PDN) affects at least one in five adults with diabetes and has a major impact due to associated depression, anxiety and sleep disturbance [1].”
BackgroundSelf-citationChao, C., Tseng, M., Hsieh, P.-C., Lin, C., Huang, S., Hsieh, S., & Chiang, M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab754 · Cited by 30
The characteristics of pain and dysesthesia in patients with diabetic polyneuropathy
Gylfadottir, S. S., Itani, M., Kristensen, A. G., Karlsson, P., Krøigård, T., Bennett, D., Tankişi, H., Andersen, N. T., Jensen, T. S., Sindrup, S. H., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263831 · Cited by 34
Best, T. J., Best, C. A. E., Best, A. A., & Fera, L. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.08.002 · Cited by 30
Määttä, L. L., Charles, M., Witte, D. R., Bjerg, L., Jørgensen, M. E., Jensen, T. S., & Andersen, S. T. (2019) · Diabetes Care · doi:10.2337/dc19-0869 · Cited by 31
Scuteri, D., Guida, F., Boccella, S., Palazzo, E., Maione, S., Rodríguez‐Landa, J. F., Martínez-Mota, L., Tonin, P., Bagetta, G., & Corasaniti, M. T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081672 · Cited by 32
“Neuropathic pain, being caused by a lesion or disease of the somatosensory system [4], can be due to spinal surgery procedures [5] or injury [6] and also stroke [7], but also to neuropathies caused by comorbidities reaching up to 60% in prevalence, such as diabetes [8] and shingles due to herpes zoster infection, as s…”
BackgroundSystematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy
Duarte, R. V., Nevitt, S. J., Copley, S., Maden, M., de Vos, C. C., Taylor, R. S., & Eldabe, S. S. (2022) · Diabetes Care · doi:10.2337/dc22-0932 · Cited by 32
Pharmacologic management of diabetic peripheral neuropathic pain
Iyer, S. N., & Tanenberg, R. J. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.811490 · Cited by 32
He, W., Zhang, B., Xiong, Q., Yang, C., Zhao, W., He, J., Zhou, J., & Wang, H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.064 · Cited by 37
“of diabetic patients experience neuropathic pain [2].”
Insights into the pathogenesis and treatment of painful diabetic neuropathy
Greig, M., Tesfaye, S. H., Selvarajah, D., & Wilkinson, I. D. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00037-0 · Cited by 34
Tatikola, S. P., Natarajan, V., Desai, V. K., Asirvatham, A. R., & Rajsekhar, H. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102603 · Cited by 34
Conventional management and current guidelines for painful diabetic neuropathy
Tesfaye, S. H., & Kempler, P. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110765 · Cited by 40
Diabetic Peripheral Neuropathy: Emerging Treatments of Neuropathic Pain and Novel Diagnostic Methods
Røikjer, J., Borbjerg, M. K., Andresen, T., Giordano, R., Hviid, C. V. B., Mørch, C. D., Karlsson, P., Klonoff, D. C., Arendt‐Nielsen, L., & Ejskjær, N. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241279553 · Cited by 43
“…intervention has mainly focused on the often-accompanying neuropathic pain, which might affect as much as 30% to 50% of the population with DPN. 9,10 Because of the lack of drugs targeting the proposed mechanisms of painful DPN, the treatment is solely symptomatic and is often associated with…”
Silva, M., Costa‐Pereira, J. T., Martins, D., & Tavares, I. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.10.002 · Cited by 31
Djouhri, L., Malki, M. I., Zeidan, A., Nagi, K., & Smith, T. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1608552 · Cited by 35
Higgins, D. M., Heapy, A. A., Buta, E., LaChappelle, K. M., Serowik, K. L., Czlapinski, R. A., & Kerns, R. D. (2020) · Journal of Health Psychology · doi:10.1177/1359105320962262 · Cited by 34
“…due to variations in disease classification and method of diagnosis (Dworkin et al., 2003); however, published reviews cite estimated prevalence ranges from 16% to 50% with incidence increasing with disease duration (Abbott et al., 2011; Daousi et al., 2004; Davies et al., 2015; Schmader, 2002).”
BackgroundNeuropathic Pain Related to Peripheral Neuropathies According to the IASP Grading System Criteria
Stefano, G. D., Lionardo, A. D., Pietro, G. D., & Truini, A. (2020) · Brain Sciences · doi:10.3390/brainsci11010001 · Cited by 37
Novel treatment modalities for painful diabetic neuropathy
Rastogi, A., & Jude, E. B. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.01.004 · Cited by 32
Park, H., Lee, J.-H., Sim, J., Park, J.-H., Choi, S.-S., & Leem, J. G. (2021) · Pain Research and Management · doi:10.1155/2021/8787231 · Cited by 32
“Neuropathic pain is one of the most common complications of diabetes mellitus (DM) and an estimated one-third of patients with DM have painful diabetic neuropathy [1].”
BackgroundPrevalence and treatment of neuropathic pain diagnoses among U.S. nursing home residents
Mbrah, A. K., Nunes, A. P., Hume, A. L., Zhao, D., Jesdale, B. M., Bova, C., & Lapane, K. L. (2021) · Pain · doi:10.1097/j.pain.0000000000002525 · Cited by 29
Mousa, S. A., Shaqura, M. A., Winkler, J., Khalefa, B. I., Al-Madol, M. A., Shakibaei, M., Schulz, S., & Schäfer, M. (2015) · Pain · doi:10.1097/j.pain.0000000000000459 · Cited by 29
Taheri, A. A., Foroughi, A. A., Mohammadian, Y., Ahmadi, S. M., Heshmati, K., Hezarkhani, L. A., & Parvizifard, A. A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00851-9 · Cited by 28
Enomoto, H., Yasuda, H., Nishiyori, A., Fujikoshi, S., Furukawa, M., Ishida, M., Takahashi, M., Tsuji, T., Yoshikawa, A., & Alev, L. (2018) · Journal of Pain Research · doi:10.2147/jpr.s170646 · Cited by 29
“2 Neuropathic pain is one of the most frequent complications of diabetes, 5,6 and up to 22% of Japanese diabetic patients have painful diabetic neuropathy.”
Ogata, Y., Nemoto, W., Yamagata, R., Nakagawasai, O., Shimoyama, S., Furukawa, T., Ueno, S., & Tan–No, K. (2018) · European Journal of Pain · doi:10.1002/ejp.1341 · Cited by 27
“According to published papers, 50%–60% of patients with diabetic neuropathy experience neuropathic pain (Galer et al., 2000; Gordois et al., 2003; Abbott et al., 2011).”
BackgroundPrevalence and Determinants of Painful and Painless Neuropathy in Type 1 Diabetes Mellitus
Barbosa, M., Saavedra, A., Oliveira, S. C., Reis, L. D. D., Rodrigues, F., Severo, M., Sittl, R., Maier, C., & Carvalho, D. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00402 · Cited by 33
“However, in a UK study (34) a significantly great proportion of female patients reported painful neuropathy symptoms despite a lower frequency of clinical neuropathy.”
BackgroundNeuropathic-like pain in psoriatic arthritis: evidence of abnormal pain processing
Ramjeeawon, A., & Choy, E. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04656-5 · Cited by 33
Abdissa, D. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00661-7 · Cited by 32
Xiaohua, G., Dongdong, L., Xiaoting, N., Shuoping, C., Feixia, S., Huajun, Y., Zhou, Q., & Zimiao, C. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.612068 · Cited by 28
Nagata, K., Nakamoto, H., Sumitani, M., Kato, S., Yoshida, Y., Kawamura, N., Tozawa, K., Takeshita, Y., Nakarai, H., Higashikawa, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87615-y · Cited by 29
“The exclusion criteria were (1) age < 20 years; (2) including thoracic level; (3) emergency surgery; (4) revision surgery; (5) surgeries involving osteotomy; and (6) surgical site involving > 3 levels.”
BackgroundChen, J. L., Frizzi, K. E., Zardouz, S., Province‐Azalde, R., Furnish, T. J., Wallace, M. S., Castellanos, J. P., Tayarani, A., Halter, K., Lam, K., et al. (2023) · Pain Medicine · doi:10.1093/pm/pnad096 · Cited by 28
Aslam, A., Singh, J., & Rajbhandari, S. M. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.12.007 · Cited by 29
Is Diabetic Nerve Pain Caused by Dysregulated Ion Channels in Sensory Neurons?
Todorovic, S. M. (2015) · Diabetes · doi:10.2337/dbi15-0006 · Cited by 28
Rolim, L. C., da Silva, E. M. K., de Sá, J. R., & Dib, S. A. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00285 · Cited by 34
Diagnosis and management of patients with polyneuropathy
Mirian, A., Aljohani, Z., Grushka, D. H., & Florendo-Cumbermack, A. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.220936 · Cited by 27
Fadavi, H., Tavakoli, M., Foden, P., Ferdousi, M., Petropoulos, I. N., Jeziorska, M., Chaturvedi, N., Boulton, A. J. M., Malik, R. A., & Abbott, C. A. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3044 · Cited by 26
“Myocardial infarction (%) 12/69 (17) 12/75 (16) 0.”
Self-citationAmara, F., Hafez, S., Orabi, A., Etriby, A. E., Rahim, A. A. A., Zakaria, E., Koura, F., Talaat, F., Gawish, H., Attia, I., et al. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190226150402 · Cited by 27
The Effect of Intradermal Botulinum Toxin a injections on painful diabetic polyneuropathy
Taheri, M., Sedaghat, M., Solhpour, A., et al. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.09.019 · Cited by 27
Ferdousi, M., Azmi, S., Kalteniece, A., Petropoulos, I. N., Ponirakis, G., Asghar, O., Alam, U., Marshall, A. G., Boulton, A. J. M., Efron, N., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.14757 · Cited by 30
“Approximately 20% of patients with diabetic peripheral neuropathy (DPN) develop painful neuropathy which is associated with significant morbidity and reduced quality of life.[1] The efficacy of current therapies is highly variable,[2,3] which may in part reflect diverse etiological mechanisms operating at the peripher…”
BackgroundResultSelf-citationThe prevalence of painful diabetic neuropathy in 300 Moroccan diabetics
Chahbi, Z., Lahmar, B., Elhadri, S., Abainou, L., Kaddouri, S., Qaçif, H., Baïzri, H., & Zyani, M. (2018) · Pan African Medical Journal · doi:10.11604/pamj.2018.31.158.14687 · Cited by 27
McKune, C. M., Murrell, J. C., Nolan, A. M., White, K., & Wright, B. D. (2015) · Wiley eBooks · doi:10.1002/9781119421375.ch29 · Cited by 42
Vasdeki, D., Tsamos, G., Dimakakos, E. P., Patriarcheas, V., Koufakis, T., Kotsa, K., Cholewka, A., & Stanek, A. (2024) · Nutrients · doi:10.3390/nu16213651 · Cited by 36
“A UK study of 15,692 patients revealed that 34% of South Asians and 21% of Europeans experienced painful DPN, indicating ethnic disparities [188].”
BackgroundZhang, Q., Zhang, P., Yan, R., Xu, X., Mao, C., Liu, X., Li, F.-F., Ma, J., Ye, L., Yao, Z., et al. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0534-x · Cited by 27
Franken, G., Debets, J., & Joosten, E. A. J. (2018) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12908 · Cited by 29
Hu, W., Ding, Y., Li, Q., Shi, R., & He, Y. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13244 · Cited by 26
Baxi, H., Habib, A., Hussain, M. S., Hussain, S., & Dubey, K. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00597-y · Cited by 32
Kato, J., Inoue, T., Yokoyama, M., & Kuroha, M. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1958780 · Cited by 31
Contemporary management of pain in cirrhosis: Toward precision therapy for pain
Holman, A., Parikh, N. D., Clauw, D. J., Williams, D. A., & Tapper, E. B. (2022) · Hepatology · doi:10.1002/hep.32598 · Cited by 32
“[129,130] Peripheral neuropathy, which can be associated with neuropathic pain symptoms,[131] is common in chronic liver disease and appears to be independent of coexisting diabetes or alcohol abuse.”
BackgroundShort-Term Efficacy of Ultramicronized Palmitoylethanolamide in Peripheral Neuropathic Pain
Cocito, D., Peci, E., Ciaramitaro, P., Merola, A., & Lopiano, L. (2014) · Pain Research and Treatment · doi:10.1155/2014/854560 · Cited by 26
Rajan, R. S., de Gray, L., & George, E. (2013) · Continuing Education in Anaesthesia Critical Care & Pain · doi:10.1093/bjaceaccp/mkt063 · Cited by 28
Loss of POMC-mediated antinociception contributes to painful diabetic neuropathy
Deshpande, D., Agarwal, N. K., Fleming, T. H., Gavériaux‐Ruff, C., Klose, C. S. N., Tappe‐Theodor, A., Kuner, R., & Nawroth, P. P. (2021) · Nature Communications · doi:10.1038/s41467-020-20677-0 · Cited by 29
Zhou, P., Zhou, J., Li, J., Qin, L., Hu, W. F., Zhang, X., Wang, J. X., & Shi, Z. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1564867 · Cited by 37
Goel, A., Shivaprasad, C., Kolly, A., Sarathi, V., & Atluri, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183973 · Cited by 27
Kaewput, W., Thongprayoon, C., Rangsin, R., Jindarat, S., Narindrarangkura, P., Bathini, T. J., Mao, M. A., & Cheungpasitporn, W. (2020) · Korean Journal of Family Medicine · doi:10.4082/kjfm.18.0205 · Cited by 26
Jiang, Z., Bian, M., Wu, J., Li, D., Ding, L., & Zeng, Q. (2020) · BioMed Research International · doi:10.1155/2020/5939815 · Cited by 25
Alyoubi, R. A., Alshareef, A. A., Aldughaither, S. M., Aljaroudi, A. M., Alabdulwahed, A. A., Alduraibi, F. M., Masoud, A. T., & Abu‐Zaid, A. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13744 · Cited by 25
Advances in diet-induced rodent models of metabolically acquired peripheral neuropathy
Eid, S., & Feldman, E. L. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049337 · Cited by 27
Association of Genetic Variant at Chromosome 12q23.1 With Neuropathic Pain Susceptibility
Veluchamy, A., Hébert, H. L., van Zuydam, N. R., Pearson, E. R., Campbell, A., Hayward, C., Meng, W., McCarthy, M. I., Bennett, D., Palmer, C. N. A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.36560 · Cited by 27
Animal Models of Diabetes-Induced Neuropathic Pain
Lee-Kubli, C. A., Mixcoatl-Zecuatl, T., Jolivalt, C. G., & Calcutt, N. A. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_280 · Cited by 29
“The prevalence of painful symptoms in the diabetic population is estimated to be as high as 34 % (Harris et al. 1993; Partanen et al. 1995; Boulton et al. 1985; Sorensen et al. 2002; Abbott et al. 2011), with a slightly higher incidence among type 2 diabetic patients (Abbott et al. 2011).”
BackgroundLee-Kubli, C. A., & Calcutt, N. A. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00034-5 · Cited by 27
Rasmussen, M. L., Broe, R., Frydkjær-Olsen, U., Olsen, B. S., Mortensen, H. B., Pető, T., & Grauslund, J. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3454-3 · Cited by 27
Todorovic, S. M. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.03.005 · Cited by 27
“Interestingly, these painful pathologies in diabetics usually occur in parallel with degeneration of peripheral nerves (Abbott et al., 2011).”
BackgroundVasigh, A., Abdi, A., Borji, M., & Tarjoman, A. (2019) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2018-0223 · Cited by 25
Zhu, Y.-B., Jia, G., Wang, J.-W., Ye, X.-Y., Lu, J.-H., Chen, J.-L., Zhang, M., Xie, C.-S., Shen, Y.-J., Tao, Y., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa035 · Cited by 27
Metadata
- Authors
- Abbott, C. A., Malik, R. A., van Ross, E. R. E., Kulkarni, J., & Boulton, A. J. M.
- Affiliations
- University of Manchester (GB)
- Disablement Services Centre, Withington Hospital, Manchester, U.K.
- Withington Community Hospital (GB)
- Corresponding author
- Abbott, Caroline A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-09-15
- Volume
- 34
- Issue
- 10
- Pages
- 2220-2224
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3177727
- OpenAlex
- W2162902338
- Semantic Scholar
- f503e4898de5486de267534e888652f729e9319c
- Cited by
- 868
- References
- 19
- Citations by year
- 2026: 38 · 2025: 67 · 2024: 74 · 2023: 69 · 2022: 70 · 2021: 97 · 2020: 99 · 2019: 64 · 2018: 54 · 2017: 48 · 2016: 47 · 2015: 52 · 2014: 41 · 2013: 35 · 2012: 12
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- e-space (Manchester Metropolitan University) (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Diabetes Association
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Keywords
- diabetic neuropathic pain, prevalence, type 2 diabetes, type 1 diabetes, sex differences, ethnicity, South Asians, neuropathy severity, neuropathic pain, neuropathy screening
- MeSH terms
- Administration, Oral, Adult, Aged, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Female, United Kingdom, Humans, Hypoglycemic Agents, Male, Middle Aged, Sex Factors, Age Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
